PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
68.10
-0.04 (-0.06%)
At close: May 17, 2024, 4:00 PM
67.49
-0.61 (-0.90%)
After-hours: May 17, 2024, 6:49 PM EDT
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for PROCEPT BioRobotics stock have an average target of 61.2, with a low estimate of 37 and a high estimate of 75. The average target predicts a decrease of -10.13% from the current stock price of 68.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRCT stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $65 → $75 | Strong Buy | Maintains | $65 → $75 | +10.13% | May 6, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $67 → $75 | Buy | Maintains | $67 → $75 | +10.13% | May 6, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $63 → $72 | Strong Buy | Maintains | $63 → $72 | +5.73% | May 2, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $55 → $58 | Strong Buy | Maintains | $55 → $58 | -14.83% | Feb 28, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | -30.98% | Jan 9, 2024 |
Financial Forecast
Revenue This Year
214.38M
from 136.19M
Increased by 57.41%
Revenue Next Year
301.56M
from 214.38M
Increased by 40.67%
EPS This Year
-2.04
from -2.24
EPS Next Year
-1.55
from -2.04
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 221.9M | 321.2M | 431.1M | 506.7M | 595.4M |
| Avg | 214.4M | 301.6M | 405.5M | 484.9M | 569.2M |
| Low | 205.5M | 264.5M | 370.6M | 458.8M | 538.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 62.9% | 49.8% | 42.9% | 25.0% | 22.8% |
| Avg | 57.4% | 40.7% | 34.5% | 19.6% | 17.4% |
| Low | 50.9% | 23.4% | 22.9% | 13.1% | 11.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.03 | -1.10 | -0.44 | -0.09 | 0.47 |
| Avg | -2.04 | -1.55 | -0.97 | -0.20 | 0.46 |
| Low | -2.02 | -1.74 | -1.29 | -0.30 | 0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.